
Nadeem Iqbal
Examiner (ID: 5411, Phone: (571)272-3659 , Office: P/2114 )
| Most Active Art Unit | 2114 |
| Art Unit(s) | 2184, 2114, 2785, 2413 |
| Total Applications | 2131 |
| Issued Applications | 1930 |
| Pending Applications | 59 |
| Abandoned Applications | 146 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18469309
[patent_doc_number] => 20230203593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHOD FOR CARRYING OUT IN VITRO MOLECULAR DIAGNOSIS OF OVARIAN TUMOR AND KIT
[patent_app_type] => utility
[patent_app_number] => 17/925995
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925995 | METHOD FOR CARRYING OUT IN VITRO MOLECULAR DIAGNOSIS OF OVARIAN TUMOR AND KIT | May 18, 2021 | Pending |
Array
(
[id] => 18361704
[patent_doc_number] => 20230143295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => METHODS AND KITS FOR DETERMINING THE RISK OF BREAST CANCER RECURRENCE
[patent_app_type] => utility
[patent_app_number] => 17/907601
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907601 | METHODS AND KITS FOR DETERMINING THE RISK OF BREAST CANCER RECURRENCE | May 6, 2021 | Pending |
Array
(
[id] => 17067650
[patent_doc_number] => 20210269865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => Methods for Attaching Cellular Constituents to a Matrix
[patent_app_type] => utility
[patent_app_number] => 17/241146
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241146 | Methods for Attaching Cellular Constituents to a Matrix | Apr 26, 2021 | Pending |
Array
(
[id] => 17037187
[patent_doc_number] => 20210254145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Methods for Attaching Cellular Constituents to a Matrix
[patent_app_type] => utility
[patent_app_number] => 17/241157
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241157 | Methods for Attaching Cellular Constituents to a Matrix | Apr 26, 2021 | Pending |
Array
(
[id] => 18408689
[patent_doc_number] => 20230170042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => STRUCTURAL VARIATION DETECTION IN CHROMOSOMAL PROXIMITY EXPERIMENTS
[patent_app_type] => utility
[patent_app_number] => 17/919970
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/919970 | STRUCTURAL VARIATION DETECTION IN CHROMOSOMAL PROXIMITY EXPERIMENTS | Apr 22, 2021 | Abandoned |
Array
(
[id] => 18348606
[patent_doc_number] => 20230136717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => EPLIN AS A BIOMARKER FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 17/917902
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917902 | EPLIN AS A BIOMARKER FOR CANCER | Apr 8, 2021 | Pending |
Array
(
[id] => 18364348
[patent_doc_number] => 20230145939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => MARKER COMPOSITION FOR CANCER DIAGNOSIS OR PROGNOSIS BASED ON EXOSOME OVEREXRESSING GCC2
[patent_app_type] => utility
[patent_app_number] => 17/918492
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918492 | MARKER COMPOSITION FOR CANCER DIAGNOSIS OR PROGNOSIS BASED ON EXOSOME OVEREXRESSING GCC2 | Apr 4, 2021 | Pending |
Array
(
[id] => 18296802
[patent_doc_number] => 20230106488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => METHOD FOR DETERMINING SECRETED LEVELS OF FUCOSYLATED HUMAN MILK OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/907137
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907137 | METHOD FOR DETERMINING SECRETED LEVELS OF FUCOSYLATED HUMAN MILK OLIGOSACCHARIDES | Mar 25, 2021 | Pending |
Array
(
[id] => 16948511
[patent_doc_number] => 20210207202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Spatially Encoded Biological Assays
[patent_app_type] => utility
[patent_app_number] => 17/211231
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17211231
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/211231 | Spatially Encoded Biological Assays | Mar 23, 2021 | Abandoned |
Array
(
[id] => 18545532
[patent_doc_number] => 11718873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Correcting for deamination-induced sequence errors
[patent_app_type] => utility
[patent_app_number] => 17/210202
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18062
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210202 | Correcting for deamination-induced sequence errors | Mar 22, 2021 | Issued |
Array
(
[id] => 16992259
[patent_doc_number] => 20210230679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHODS OF EPIGENETIC ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 17/208940
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208940
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208940 | METHODS OF EPIGENETIC ANALYSIS | Mar 21, 2021 | Abandoned |
Array
(
[id] => 17200514
[patent_doc_number] => 20210340609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => GENOTYPING BY POLYMERASE BINDING
[patent_app_type] => utility
[patent_app_number] => 17/198932
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198932 | GENOTYPING BY POLYMERASE BINDING | Mar 10, 2021 | Abandoned |
Array
(
[id] => 18297052
[patent_doc_number] => 20230106738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => COMPOSITIONS, METHODS, AND KITS FOR DETECTING THE NUMBER AND GENOMIC LOCATIONS OF POLYMORPHIC LINE-1 ELEMENTS IN AN INDIVIDUAL
[patent_app_type] => utility
[patent_app_number] => 17/802523
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802523 | COMPOSITIONS, METHODS, AND KITS FOR DETECTING THE NUMBER AND GENOMIC LOCATIONS OF POLYMORPHIC LINE-1 ELEMENTS IN AN INDIVIDUAL | Feb 28, 2021 | Pending |
Array
(
[id] => 18420579
[patent_doc_number] => 20230175041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => DYNAMIC FRET-BASED SINGLE-MOLECULE SENSOR FOR ULTRASENSITIVE DETECTION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/904741
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904741 | DYNAMIC FRET-BASED SINGLE-MOLECULE SENSOR FOR ULTRASENSITIVE DETECTION OF NUCLEIC ACIDS | Feb 24, 2021 | Pending |
Array
(
[id] => 16948509
[patent_doc_number] => 20210207200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Compositions and Methods for Analyzing Modified Nucleotides
[patent_app_type] => utility
[patent_app_number] => 17/181351
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/181351 | Compositions and methods for analyzing modified nucleotides | Feb 21, 2021 | Issued |
Array
(
[id] => 18225280
[patent_doc_number] => 20230064274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => MARKER SELECTION METHOD USING METHYLATION DIFFERENCE BETWEEN NUCLEIC ACIDS, METHYLATED OR DEMETHYLATED MARKER, AND DIAGNOSTIC METHOD USING MARKER
[patent_app_type] => utility
[patent_app_number] => 17/436550
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436550 | MARKER SELECTION METHOD USING METHYLATION DIFFERENCE BETWEEN NUCLEIC ACIDS, METHYLATED OR DEMETHYLATED MARKER, AND DIAGNOSTIC METHOD USING MARKER | Feb 18, 2021 | Pending |
Array
(
[id] => 20433438
[patent_doc_number] => 12503728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Methods and systems for high-depth sequencing of methylated nucleic acid
[patent_app_type] => utility
[patent_app_number] => 17/173770
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19734
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173770 | Methods and systems for high-depth sequencing of methylated nucleic acid | Feb 10, 2021 | Issued |
Array
(
[id] => 18244638
[patent_doc_number] => 20230076949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => TARGETED, LONG-READ NUCLEIC ACID SEQUENCING FOR THE DETERMINATION OF CYTOSINE MODIFICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/929033
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929033 | Targeted, long-read nucleic acid sequencing for the determination of cytosine modifications | Feb 9, 2021 | Issued |
Array
(
[id] => 19410905
[patent_doc_number] => 12076701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Capturing oligonucleotides in spatial transcriptomics
[patent_app_type] => utility
[patent_app_number] => 17/161007
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18764
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161007
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/161007 | Capturing oligonucleotides in spatial transcriptomics | Jan 27, 2021 | Issued |
Array
(
[id] => 18567487
[patent_doc_number] => 20230257821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHODS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/792612
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792612
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792612 | METHODS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA | Jan 14, 2021 | Pending |